Tardive dyskinesia (TD) is a severe latrogenic disorder which develops gradually in schizophrenics treated with chronic neuroleptics. This laboratory has developed a highly unique animal model of tardive dyskinesia based upon a computerized system in which measures of oral movements (OMs) in rats are directly placed into computer memory together with the reports of human observers. The results obtained using this highly novel and rigorous approach are very different from those obtained using simple observational techniques, and suggest the best model of TD in rats is the tiny tremorous oscillations of the lips which rats begin to show only after many months of chronic neuroleptic administration and which are largely undetected by the naked eye. We now propose to further investigate this promising animal model of tardive dyskinesia by clarifying, through further computer analysis and amplified recording procedures, what the small oral oscillations actually represent. Other studies will access whether different regimens of neuroleptic administration alter the development of persistant side effects of chronic neuroleptics, including whether fluctuating or very steady levels of neuroleptics are more prone to induce the disorder. We also propose to compare the extent to which various classes of neuroleptics (including several novel, atypical neuroleptics) induce this disorder, and whether the concurrent administration of selected dopamine stimulants (D1 v. D2 agonists) facilitate or hinder the development of the syndrome. Other studies will further investigate the pharmacology of oral movements using drugs which act on dopamine, or acetylcholine, or GABA systems within the brain, and then compare effects of these compounds on TD-like vacuous OMs in chronic animals. Detailed regional, autoradiographic studies of receptor binding will be conducted on chronic neuroleptic animals at the completion of these experiments so that varying degrees of symptomatology can be correlated with regional alterations in brain biochemistry. These experiments address an important research issue involving a widespread iatrogenic disorder. The experimental questions addressed in this proposal will probably only be answered in the near future using an animal model such as that proposed here.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH039961-06
Application #
3377775
Study Section
Neurosciences Research Review Committee (BPN)
Project Start
1984-12-01
Project End
1991-11-30
Budget Start
1990-01-01
Budget End
1991-11-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ellison, G; See, R E (1990) Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats. Pharmacol Biochem Behav 36:807-11
Levin, E D; See, R E; South, D (1989) Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats. Pharmacol Biochem Behav 34:43-8
Levin, E D; Ellison, G D; See, R E et al. (1989) D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats. Pharmacol Biochem Behav 33:501-5
Weinstein, D; See, R E; Ellison, G (1989) Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs. Pharmacol Biochem Behav 32:1057-60
Ellison, G; See, R E (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology (Berl) 98:564-6
See, R E; Levin, E D; Ellison, G D (1988) Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology (Berl) 94:421-7
Ellison, G; Johansson, P; Levin, E et al. (1988) Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. Psychopharmacology (Berl) 96:253-7
Johansson, P; Levin, E; Gunne, L et al. (1987) Opposite effects of a D1 and a D2 agonist on oral movements in rats. Eur J Pharmacol 134:83-8
Levy, A D; Ellison, G D (1987) Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats. Psychopharmacology (Berl) 93:218-22
Levin, E D; Galen, D M; Ellison, G D (1987) Chronic haloperidol effects on oral movements and radial-arm maze performance in rats. Pharmacol Biochem Behav 26:1-6

Showing the most recent 10 out of 15 publications